Aspicio Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $400K

  • Investors
  • 1

Aspicio Therapeutics General Information

Description

Developer of a biologic therapy intended to promote synaptogenesis and directly affect the vision loss experienced by patients. This company is currently operating in Stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 250 Truman Way
  • Downington, PA 19335
  • United States
+1 (484)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 250 Truman Way
  • Downington, PA 19335
  • United States
+1 (484)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspicio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 21-Jun-2024 $400K Completed Stealth
To view Aspicio Therapeutics’s complete valuation and funding history, request access »

Aspicio Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioAdvance Capital (Conshohocken) Venture Capital Minority
To view Aspicio Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Aspicio Therapeutics FAQs

  • When was Aspicio Therapeutics founded?

    Aspicio Therapeutics was founded in 2024.

  • Where is Aspicio Therapeutics headquartered?

    Aspicio Therapeutics is headquartered in Downington, PA.

  • What industry is Aspicio Therapeutics in?

    Aspicio Therapeutics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Aspicio Therapeutics a private or public company?

    Aspicio Therapeutics is a Private company.

  • What is Aspicio Therapeutics’s current revenue?

    The current revenue for Aspicio Therapeutics is .

  • How much funding has Aspicio Therapeutics raised over time?

    Aspicio Therapeutics has raised $400K.

  • Who are Aspicio Therapeutics’s investors?

    BioAdvance Capital (Conshohocken) has invested in Aspicio Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »